Preferred Label : marstacimab;
UNII : 0UB3OA67O7;
Origin ID : C000656192;
UMLS CUI : C5226892;
ATC code(s)
- Currated CISMeF NLP mapping
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3597499/fr/hympavzi-marstacimab-hemophilie
2025
false
false
false
France
hemorrhage
evaluation of the transparency committee
marstacimab
hemophilia A
---
https://www.has-sante.fr/jcms/p_3606841/fr/hympavzi-marstacimab-hemophilie
2025
false
false
false
France
French
treatment outcome
hemorrhage
hemophilia B
hemophilia A
marstacimab
marstacimab
antibodies, monoclonal, humanized
injections, subcutaneous
adolescent
adult
evaluation of the transparency committee
---
https://www.ema.europa.eu/en/medicines/human/EPAR/hympavzi
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
marstacimab
marstacimab
marstacimab
drug approval
europe
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
adolescent
adult
hemorrhage
hemophilia B
hemophilia A
injections, subcutaneous
tissue factor pathway inhibitor
risk management
product surveillance, postmarketing
aged
pregnancy
breast feeding
drug evaluation, preclinical
---
